Australia TGA ARTG recordSevere acute respiratory syndrome-associated coronavirus IVDs
Australia TGA ARTG Registered Device · R-Biopharm Pty Ltd · Diesse Diagnostica Senese SPA · Class IIb · Started March 30, 2021
Good Name: R-Biopharm Pty Ltd - Severe acute respiratory syndrome-associated coronavirus IVDs
- Risk Class
- Class IIb
- Product Type
- IVD
- ARTG Category
- IVD
- Start Date
- March 30, 2021
- Effective Date
- January 30, 2023
- Country
- Italy
- Address
- Via Delle Rose 10, Monteriggioni, Italy, 53035
Severe acute respiratory syndrome-associated coronavirus IVDs
Access comprehensive regulatory information for Severe acute respiratory syndrome-associated coronavirus IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by R-Biopharm Pty Ltd, manufactured by Diesse Diagnostica Senese SPA in Italy. The device registration started on March 30, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.